US hypertension and cholesterol management guidelines

New medical guidelines from the American Heart Association and the American College of Cardiology have expanded the criteria for managing hypertension and cholesterol in the United States to prevent cardiovascular disease.

Initial reports indicated that approximately 81 million Americans might become eligible for blood pressure medications under updated guidelines that consider factors such as kidney function and blood sugar. Researchers estimated that expanded treatment could prevent roughly 200,900 all-cause deaths and 162,600 cardiovascular deaths over the next decade. Studies also noted a discrepancy in patient behavior, where individuals were more likely to follow medication regimens than to adopt recommended lifestyle changes.

Subsequent details clarified the specific blood pressure classifications: healthy readings are defined as not exceeding 120/80 mmHg, while readings between 120-129/80 mmHg are classified as elevated. For systolic pressures between 130-139 mmHg, the guidelines advise doctors to recommend lifestyle modifications, such as dietary changes and increased physical activity, for a period of 3-6 months before considering medication. Additionally, dietary choices involving products like oats, olive oil, and fatty fish were highlighted for their role in supporting cardiovascular health and lowering cholesterol.

A study published in the Journal of the American Heart Association further highlights a management gap, noting that nearly one in three American adults with untreated high blood pressure could benefit from medical intervention but are not receiving it. Research from institutions including the University of Pennsylvania suggests that the psychological drivers for taking medication and making lifestyle changes may be distinct, as patients are often less inclined to adopt diet and exercise recommendations despite being motivated to follow medication regimens.